HEADER TRANSFERASE 29-MAR-20 6YHE TITLE TRNA-GUANINE TRANSGLYCOSYLASE (TGT) LABELED WITH 5-FLUOROTRYPTOPHAN IN TITLE 2 CO-CRYSTALLIZED COMPLEX WITH 6-AMINO-4-(2-((3AR,4R,6R,6AR)-6-METHOXY- TITLE 3 2,2-DIMETHYLTETRAHYDROFURO[3,4-D][1,3]DIOXOL-4-YL)ETHYL)-2- TITLE 4 (METHYLAMINO)-1H-IMIDAZO[4,5-G]QUINAZOLIN-8(7H)-ONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: QUEUINE TRNA-RIBOSYLTRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: GUANINE INSERTION ENZYME,TRNA-GUANINE TRANSGLYCOSYLASE; COMPND 5 EC: 2.4.2.29; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ZYMOMONAS MOBILIS SUBSP. MOBILIS ZM4 = ATCC SOURCE 3 31821; SOURCE 4 ORGANISM_TAXID: 264203; SOURCE 5 GENE: TGT, ZMO0363; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE, TGT, TRNA-GUANINE TRANSGLYCOSYLASE, GUANINE INSERTION KEYWDS 2 ENZYME, HOMODIMER, 19F NMR EXPDTA X-RAY DIFFRACTION AUTHOR A.NGUYEN,A.HEINE,G.KLEBE REVDAT 2 24-JAN-24 6YHE 1 REMARK REVDAT 1 08-APR-20 6YHE 0 JRNL AUTH A.NGUYEN,A.HEINE,G.KLEBE JRNL TITL CO-CRYSTALLIZATION, 19F NMR AND NANOESI-MS REVEAL DIMER JRNL TITL 2 DISTURBING INHIBITORS AND CONFORMATIONAL CHANGES AT DIMER JRNL TITL 3 CONTACTS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.54 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.16_3549 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.54 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.63 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 55567 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.151 REMARK 3 R VALUE (WORKING SET) : 0.149 REMARK 3 FREE R VALUE : 0.183 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2777 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.6300 - 4.1900 0.96 2681 142 0.1682 0.1883 REMARK 3 2 4.1900 - 3.3300 0.98 2693 141 0.1442 0.1627 REMARK 3 3 3.3300 - 2.9100 0.99 2704 143 0.1438 0.1587 REMARK 3 4 2.9100 - 2.6400 0.96 2593 136 0.1433 0.1701 REMARK 3 5 2.6400 - 2.4500 0.98 2675 141 0.1374 0.1563 REMARK 3 6 2.4500 - 2.3100 0.99 2652 140 0.1326 0.1867 REMARK 3 7 2.3100 - 2.1900 0.98 2680 141 0.1360 0.1832 REMARK 3 8 2.1900 - 2.1000 0.99 2692 140 0.1353 0.1851 REMARK 3 9 2.1000 - 2.0100 0.99 2669 141 0.1371 0.1987 REMARK 3 10 2.0100 - 1.9500 0.99 2688 141 0.1360 0.2017 REMARK 3 11 1.9500 - 1.8800 0.93 2506 132 0.1496 0.1929 REMARK 3 12 1.8800 - 1.8300 0.98 2626 138 0.1475 0.2113 REMARK 3 13 1.8300 - 1.7800 0.98 2662 141 0.1566 0.1954 REMARK 3 14 1.7800 - 1.7400 0.99 2681 140 0.1622 0.2304 REMARK 3 15 1.7400 - 1.7000 0.99 2650 139 0.1613 0.2298 REMARK 3 16 1.7000 - 1.6600 0.99 2628 139 0.1685 0.2444 REMARK 3 17 1.6600 - 1.6300 0.99 2693 141 0.1720 0.2492 REMARK 3 18 1.6300 - 1.6000 1.00 2689 142 0.1736 0.2501 REMARK 3 19 1.6000 - 1.5700 0.99 2667 140 0.1953 0.2315 REMARK 3 20 1.5700 - 1.5400 0.84 2261 119 0.2418 0.2888 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.172 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.426 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.09 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2861 REMARK 3 ANGLE : 1.002 3886 REMARK 3 CHIRALITY : 0.053 409 REMARK 3 PLANARITY : 0.007 515 REMARK 3 DIHEDRAL : 19.237 1693 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6YHE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-MAR-20. REMARK 100 THE DEPOSITION ID IS D_1292107589. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-DEC-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9184 REMARK 200 MONOCHROMATOR : DCM SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55577 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.540 REMARK 200 RESOLUTION RANGE LOW (A) : 42.630 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.54 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.64 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1PUD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES PH 5.5, 0.5 MM DTT, 10% REMARK 280 (V/V) DMSO, 13% (M/V) PEG8000, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 288K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 42.32850 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.41000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 42.32850 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 32.41000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2320 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26410 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 169.31400 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 VAL A 2 REMARK 465 GLU A 3 REMARK 465 ALA A 4 REMARK 465 THR A 5 REMARK 465 ALA A 6 REMARK 465 GLN A 7 REMARK 465 GLU A 8 REMARK 465 THR A 9 REMARK 465 ALA A 49 REMARK 465 THR A 50 REMARK 465 VAL A 51 REMARK 465 LYS A 52 REMARK 465 ALA A 53 REMARK 465 LEU A 54 REMARK 465 LYS A 55 REMARK 465 PRO A 56 REMARK 465 GLU A 57 REMARK 465 THR A 58 REMARK 465 VAL A 59 REMARK 465 ARG A 60 REMARK 465 ALA A 61 REMARK 465 THR A 62 REMARK 465 SER A 113 REMARK 465 LEU A 114 REMARK 465 ARG A 384 REMARK 465 ASN A 385 REMARK 465 SER A 386 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 10 CG OD1 OD2 REMARK 470 ARG A 77 CD NE CZ NH1 NH2 REMARK 470 ARG A 82 CD NE CZ NH1 NH2 REMARK 470 GLN A 107 OE1 NE2 REMARK 470 VAL A 108 CG1 CG2 REMARK 470 MET A 109 CE REMARK 470 SER A 110 OG REMARK 470 LEU A 111 CG CD1 CD2 REMARK 470 SER A 112 OG REMARK 470 LYS A 116 CG CD CE NZ REMARK 470 GLN A 117 CD OE1 NE2 REMARK 470 GLU A 120 CG CD OE1 OE2 REMARK 470 LYS A 125 CG CD CE NZ REMARK 470 HIS A 127 CG ND1 CD2 CE1 NE2 REMARK 470 LEU A 128 CD1 CD2 REMARK 470 ASP A 129 CG OD1 OD2 REMARK 470 ARG A 132 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 167 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 190 CG CD CE NZ REMARK 470 GLU A 191 CG CD OE1 OE2 REMARK 470 GLU A 220 OE1 OE2 REMARK 470 LYS A 264 CE NZ REMARK 470 LEU A 283 CG CD1 CD2 REMARK 470 ARG A 286 NE CZ NH1 NH2 REMARK 470 ARG A 289 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 306 CZ NH1 NH2 REMARK 470 SER A 316 OG REMARK 470 HIS A 319 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 324 CG CD OE1 NE2 REMARK 470 LYS A 325 CD CE NZ REMARK 470 ILE A 340 CG2 CD1 REMARK 470 GLU A 348 CD OE1 OE2 REMARK 470 ILE A 351 CD1 REMARK 470 LYS A 360 CD CE NZ REMARK 470 ARG A 369 CZ NH1 NH2 REMARK 470 GLN A 375 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 203 -163.71 -125.26 REMARK 500 SER A 205 -132.95 57.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 72C A 402 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 318 SG REMARK 620 2 CYS A 320 SG 104.0 REMARK 620 3 CYS A 323 SG 115.4 116.1 REMARK 620 4 HIS A 349 ND1 108.0 114.4 99.2 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 72C A 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6YGY RELATED DB: PDB DBREF 6YHE A 1 386 UNP P28720 TGT_ZYMMO 1 386 SEQADV 6YHE GLY A -1 UNP P28720 EXPRESSION TAG SEQADV 6YHE SER A 0 UNP P28720 EXPRESSION TAG SEQADV 6YHE LYS A 312 UNP P28720 THR 312 ENGINEERED MUTATION SEQRES 1 A 388 GLY SER MET VAL GLU ALA THR ALA GLN GLU THR ASP ARG SEQRES 2 A 388 PRO ARG PHE SER PHE SER ILE ALA ALA ARG GLU GLY LYS SEQRES 3 A 388 ALA ARG THR GLY THR ILE GLU MET LYS ARG GLY VAL ILE SEQRES 4 A 388 ARG THR PRO ALA PHE MET PRO VAL GLY THR ALA ALA THR SEQRES 5 A 388 VAL LYS ALA LEU LYS PRO GLU THR VAL ARG ALA THR GLY SEQRES 6 A 388 ALA ASP ILE ILE LEU GLY ASN THR TYR HIS LEU MET LEU SEQRES 7 A 388 ARG PRO GLY ALA GLU ARG ILE ALA LYS LEU GLY GLY LEU SEQRES 8 A 388 HIS SER PHE MET GLY FTR ASP ARG PRO ILE LEU THR ASP SEQRES 9 A 388 SER GLY GLY TYR GLN VAL MET SER LEU SER SER LEU THR SEQRES 10 A 388 LYS GLN SER GLU GLU GLY VAL THR PHE LYS SER HIS LEU SEQRES 11 A 388 ASP GLY SER ARG HIS MET LEU SER PRO GLU ARG SER ILE SEQRES 12 A 388 GLU ILE GLN HIS LEU LEU GLY SER ASP ILE VAL MET ALA SEQRES 13 A 388 PHE ASP GLU CYS THR PRO TYR PRO ALA THR PRO SER ARG SEQRES 14 A 388 ALA ALA SER SER MET GLU ARG SER MET ARG FTR ALA LYS SEQRES 15 A 388 ARG SER ARG ASP ALA PHE ASP SER ARG LYS GLU GLN ALA SEQRES 16 A 388 GLU ASN ALA ALA LEU PHE GLY ILE GLN GLN GLY SER VAL SEQRES 17 A 388 PHE GLU ASN LEU ARG GLN GLN SER ALA ASP ALA LEU ALA SEQRES 18 A 388 GLU ILE GLY PHE ASP GLY TYR ALA VAL GLY GLY LEU ALA SEQRES 19 A 388 VAL GLY GLU GLY GLN ASP GLU MET PHE ARG VAL LEU ASP SEQRES 20 A 388 PHE SER VAL PRO MET LEU PRO ASP ASP LYS PRO HIS TYR SEQRES 21 A 388 LEU MET GLY VAL GLY LYS PRO ASP ASP ILE VAL GLY ALA SEQRES 22 A 388 VAL GLU ARG GLY ILE ASP MET PHE ASP CYS VAL LEU PRO SEQRES 23 A 388 THR ARG SER GLY ARG ASN GLY GLN ALA PHE THR FTR ASP SEQRES 24 A 388 GLY PRO ILE ASN ILE ARG ASN ALA ARG PHE SER GLU ASP SEQRES 25 A 388 LEU LYS PRO LEU ASP SER GLU CYS HIS CYS ALA VAL CYS SEQRES 26 A 388 GLN LYS FTR SER ARG ALA TYR ILE HIS HIS LEU ILE ARG SEQRES 27 A 388 ALA GLY GLU ILE LEU GLY ALA MET LEU MET THR GLU HIS SEQRES 28 A 388 ASN ILE ALA PHE TYR GLN GLN LEU MET GLN LYS ILE ARG SEQRES 29 A 388 ASP SER ILE SER GLU GLY ARG PHE SER GLN PHE ALA GLN SEQRES 30 A 388 ASP PHE ARG ALA ARG TYR PHE ALA ARG ASN SER MODRES 6YHE FTR A 95 TRP MODIFIED RESIDUE MODRES 6YHE FTR A 178 TRP MODIFIED RESIDUE MODRES 6YHE FTR A 296 TRP MODIFIED RESIDUE MODRES 6YHE FTR A 326 TRP MODIFIED RESIDUE HET FTR A 95 23 HET FTR A 178 24 HET FTR A 296 24 HET FTR A 326 23 HET ZN A 401 1 HET 72C A 402 30 HETNAM FTR FLUOROTRYPTOPHANE HETNAM ZN ZINC ION HETNAM 72C 4-[2-[(3~{A}~{R},4~{R},6~{R},6~{A}~{R})-4-METHOXY-2,2- HETNAM 2 72C DIMETHYL-3~{A},4,6,6~{A}-TETRAHYDROFURO[3,4-D][1, HETNAM 3 72C 3]DIOXOL-6-YL]ETHYL]-6-AZANYL-2-(METHYLAMINO)-1,7- HETNAM 4 72C DIHYDROIMIDAZO[4,5-G]QUINAZOLIN-8-ONE FORMUL 1 FTR 4(C11 H11 F N2 O2) FORMUL 2 ZN ZN 2+ FORMUL 3 72C C20 H26 N6 O5 FORMUL 4 HOH *241(H2 O) HELIX 1 AA1 ASN A 70 ARG A 77 1 8 HELIX 2 AA2 GLY A 79 LEU A 86 1 8 HELIX 3 AA3 GLY A 88 GLY A 94 1 7 HELIX 4 AA4 GLY A 104 SER A 112 1 9 HELIX 5 AA5 SER A 136 GLY A 148 1 13 HELIX 6 AA6 THR A 164 ARG A 189 1 26 HELIX 7 AA7 ARG A 189 ALA A 196 1 8 HELIX 8 AA8 PHE A 207 GLY A 222 1 16 HELIX 9 AA9 GLY A 236 VAL A 248 1 13 HELIX 10 AB1 PRO A 249 LEU A 251 5 3 HELIX 11 AB2 LYS A 264 GLU A 273 1 10 HELIX 12 AB3 VAL A 282 ASN A 290 1 9 HELIX 13 AB4 ASN A 304 SER A 308 5 5 HELIX 14 AB5 CYS A 320 FTR A 326 1 7 HELIX 15 AB6 SER A 327 ALA A 337 1 11 HELIX 16 AB7 GLU A 339 GLU A 367 1 29 HELIX 17 AB8 ARG A 369 PHE A 382 1 14 SHEET 1 AA1 3 SER A 15 GLU A 22 0 SHEET 2 AA1 3 ALA A 25 MET A 32 -1 O GLU A 31 N SER A 15 SHEET 3 AA1 3 GLY A 35 THR A 39 -1 O ILE A 37 N ILE A 30 SHEET 1 AA2 8 ALA A 41 PHE A 42 0 SHEET 2 AA2 8 MET A 278 PHE A 279 1 O PHE A 279 N ALA A 41 SHEET 3 AA2 8 HIS A 257 LEU A 259 1 N LEU A 259 O MET A 278 SHEET 4 AA2 8 GLY A 225 VAL A 228 1 N VAL A 228 O TYR A 258 SHEET 5 AA2 8 ALA A 197 GLN A 202 1 N GLY A 200 O ALA A 227 SHEET 6 AA2 8 ILE A 151 MET A 153 1 N VAL A 152 O ALA A 197 SHEET 7 AA2 8 ILE A 99 THR A 101 1 N THR A 101 O ILE A 151 SHEET 8 AA2 8 ILE A 67 GLY A 69 1 N ILE A 67 O LEU A 100 SHEET 1 AA3 3 LYS A 116 GLN A 117 0 SHEET 2 AA3 3 VAL A 122 LYS A 125 -1 O THR A 123 N LYS A 116 SHEET 3 AA3 3 ARG A 132 LEU A 135 -1 O LEU A 135 N VAL A 122 SHEET 1 AA4 2 GLN A 292 ALA A 293 0 SHEET 2 AA4 2 ILE A 300 ASN A 301 -1 O ILE A 300 N ALA A 293 LINK C GLY A 94 N FTR A 95 1555 1555 1.33 LINK C FTR A 95 N ASP A 96 1555 1555 1.33 LINK C ARG A 177 N FTR A 178 1555 1555 1.33 LINK C FTR A 178 N ALA A 179 1555 1555 1.33 LINK C THR A 295 N FTR A 296 1555 1555 1.32 LINK C FTR A 296 N ASP A 297 1555 1555 1.33 LINK C LYS A 325 N FTR A 326 1555 1555 1.33 LINK C FTR A 326 N SER A 327 1555 1555 1.33 LINK SG CYS A 318 ZN ZN A 401 1555 1555 2.29 LINK SG CYS A 320 ZN ZN A 401 1555 1555 2.36 LINK SG CYS A 323 ZN ZN A 401 1555 1555 2.22 LINK ND1 HIS A 349 ZN ZN A 401 1555 1555 2.26 CISPEP 1 THR A 39 PRO A 40 0 1.14 CISPEP 2 ARG A 77 PRO A 78 0 3.48 CISPEP 3 TYR A 161 PRO A 162 0 -2.46 CISPEP 4 VAL A 262 GLY A 263 0 4.36 SITE 1 AC1 4 CYS A 318 CYS A 320 CYS A 323 HIS A 349 SITE 1 AC2 16 LEU A 68 ASN A 70 ASP A 102 TYR A 106 SITE 2 AC2 16 GLN A 107 ASP A 156 CYS A 158 ILE A 201 SITE 3 AC2 16 GLN A 203 GLY A 229 GLY A 230 LEU A 231 SITE 4 AC2 16 ALA A 232 MET A 260 GLY A 261 HOH A 582 CRYST1 84.657 64.820 71.808 90.00 93.96 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011812 0.000000 0.000819 0.00000 SCALE2 0.000000 0.015427 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013959 0.00000